Sign up to save your podcasts
Or
Share Investing in Biotech: The Game Changing Technology Conexeu is Developing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Investing in Biotech: The Game Changing Technology Conexeu is Developing
It seems every day we learn about some new technology that’s changing the world. Whether it’s something we use in our day to day lives or some new scientific breakthrough that might save someone’s life. Biotechnology, or biotech, is part of the very fast growing technology field. But for everyday investors, getting into the field might have seemed far-fetched. Plus, learning about the technology and knowing what it does can be so overwhelming!
As part of our mission to educate you, the investor looking at alternative investments,Sebastian Purcell, CEO of 1.2 Capital and David Bogart, Managing Director of Conexeu Sciences, join us to talk about an exciting opportunity in the biotech space. Conexeu is building a next‑generation collagen platform designed to regenerate human tissue. David is here to tell us about it and help us non-scientific investors understand this fascinating world.
To learn more about 1.2 Capital, visit https://onepointtwocapital.com/
To learn more about Conexeu, visit https://conexeu.com/
Schedule a free call with an IRA Club New Account Specialist: https://www.iraclub.com/podcast-link/
Disclaimer: IRA Club does not provide investment, tax, financial, or legal advice, nor do we endorse any products, investments, or companies that provide such advice and investments. All parties are strongly encouraged to perform due diligence and consult with the appropriate professional(s) licensed in that area before entering any investment.
Disclaimer: 10‑Minute Tissue™: CAUTION—Investigational device (10‑Minute Tissue™). Limited by Federal (U.S.) law to investigational use. Safety and effectiveness have not been established.
View all episodes
By The IRA ClubIt seems every day we learn about some new technology that’s changing the world. Whether it’s something we use in our day to day lives or some new scientific breakthrough that might save someone’s life. Biotechnology, or biotech, is part of the very fast growing technology field. But for everyday investors, getting into the field might have seemed far-fetched. Plus, learning about the technology and knowing what it does can be so overwhelming!
As part of our mission to educate you, the investor looking at alternative investments,Sebastian Purcell, CEO of 1.2 Capital and David Bogart, Managing Director of Conexeu Sciences, join us to talk about an exciting opportunity in the biotech space. Conexeu is building a next‑generation collagen platform designed to regenerate human tissue. David is here to tell us about it and help us non-scientific investors understand this fascinating world.
To learn more about 1.2 Capital, visit https://onepointtwocapital.com/
To learn more about Conexeu, visit https://conexeu.com/
Schedule a free call with an IRA Club New Account Specialist: https://www.iraclub.com/podcast-link/
Disclaimer: IRA Club does not provide investment, tax, financial, or legal advice, nor do we endorse any products, investments, or companies that provide such advice and investments. All parties are strongly encouraged to perform due diligence and consult with the appropriate professional(s) licensed in that area before entering any investment.
Disclaimer: 10‑Minute Tissue™: CAUTION—Investigational device (10‑Minute Tissue™). Limited by Federal (U.S.) law to investigational use. Safety and effectiveness have not been established.